GeneDx Holdings WGS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
Based on trailing twelve months.
The official record: GeneDx Holdings’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's free cash flow margin?
- GeneDx Holdings (WGS) reported free cash flow margin of 3.8% in Q3 2025.
- How has GeneDx Holdings's free cash flow margin changed year-over-year?
- GeneDx Holdings's free cash flow margin increased by 117.1% year-over-year, from -22.4% to 3.8%.
- What is the long-term trend for GeneDx Holdings's free cash flow margin?
- Over 3 years (2021 to 2024), GeneDx Holdings's free cash flow margin has grown at a -50.9% compound annual growth rate (CAGR), from -94.2% to -11.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.